The Washington Post, citing the controversy over the handling of Merck's painkiller Vioxx, said in an editorial the courts are the wrong place to resolve disputes about drug safety. "Scientific judgments about the risks and advantages of drugs are not black and white -- which is why they are best made by scientists and by the regulatory agency that employs them, not by jurors through the lens of hindsight," the paper concludes.

Related Summaries